Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-24 @ 4:45 PM
NCT ID:
NCT04698850
Brief Title:
Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation
Official Title:
Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation - Prospective Randomised Study
Acronym:
BEY-RAP
Study:
NCT04698850
Protocol Section:
NCT04698850